OptiNose, Inc. (NASDAQ:OPTN) Q4 2023 Earnings Call Transcript
OptiNose, Inc. beats earnings expectations. Reported EPS is $-9.0E-5, expectations were $-0.1.
Optinose Inc. (OPTN)
Market is closed
Sector: Pharmaceutical Preparations
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Levin Easterly Partners John Murphy | 2,038,039 | $2,975,537 | +34% | 0.22% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $3.06 | 34,000 | Officer | 142,278 | 2021-05-20 | Filing | |
| $2.99 | 10,000 | Director | 31,230 | 2021-05-10 | Filing | |
| $3.91 | 11,742 | Officer, Director | 636,955 | 2021-03-18 | Filing | |
| $3.85 | 787 | Officer, Director | 625,213 | 2021-03-17 | Filing | |
| $3.90 | 2,500 | Officer | 9,751 | 2020-09-23 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $1.88 | 2,345 | Officer | 143,988 | 2024-03-18 | Filing | |
| $1.88 | 15,059 | Officer | 602,268 | 2024-03-18 | Filing | |
| $1.88 | 19,198 | Officer, Director | 1,331,278 | 2024-03-18 | Filing | |
| $1.31 | 52,875 | Officer, Director | 548,387 | 2024-01-31 | Filing | |
| $1.15 | 11,114 | Officer, Director | 509,728 | 2023-12-18 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 14,666,941 | $18,920,354 | 0% | |
| 2. | 14,605,263 | $18,767,763 | 10.93% | |
| 3. | 4,885,580 | $6,302,398 | 5.19% | |
| 4. | 4,404,251 | $5,681,483 | 0% | |
| 5. | 4,179,704 | $5,391,818 | 0% |
News See All
OptiNose, Inc. (NASDAQ:OPTN) Q3 2023 Earnings Call Transcript
Operator: Good day and thank you for standing by. Welcome to OptiNose Third Quarter 2023 Earnings Conference Call. At this time, all participants are in a listen-only mode.
OptiNose, Inc. (NASDAQ:OPTN) Q2 2023 Earnings Call Transcript
Operator: Hello. Good day everyone and thank you for standing by. Welcome to the OptiNose Second Quarter 2023 Earnings Call. At this time, all participants are in a listen only mode.
OptiNose, Inc. (NASDAQ:OPTN) Q1 2023 Earnings Call Transcript
Operator: Good day, and thank you for standing by. Welcome to the OptiNose's First Quarter 2023 Earnings Conference Call.
OptiNose, Inc. (NASDAQ:OPTN) Q4 2022 Earnings Call Transcript
Operator: Good day and thank you for standing by. Welcome to the OptiNose's Fourth Quarter 2022 Earnings Call. At this time, all participants are in a listen-only mode.
OptiNose, Inc. (NASDAQ:OPTN) Q3 2022 Earnings Call Transcript
Jonathan Neely: Third quarter 2022 performance and our plans for the remainder of the year. I'm joined today by our CEO, Peter Miller; our President and Chief Operating Officer, Dr.
10 Best Penny Stocks to Buy in July
Penny stocks are priced under $5 and often represent high-risk public companies that do offer exponential growth potential.
5 Unknown Biotech Stocks That Can Explode in 2022
In this article, we discuss the 5 unknown biotech stocks that can explode in 2022.
Is OPTN A Good Stock To Buy Now?
The latest 13F reporting period has come and gone, and Insider Monkey is again at the forefront when it comes to making use of this gold mine of data.
Here is What Hedge Funds Think About OptiNose, Inc. (OPTN)
We know that hedge funds generate strong, risk-adjusted returns over the long run, which is why imitating the picks that they are collectively bullish on can be a profitable strategy for retail investors...
Billionaire Hedge Funds
